Overview

• Institutional anchors subscribed to 1.78 crore shares at the ₹570 upper band, raising ₹1,016 crore for the offer-for-sale issue.
• The book-built IPO comprises entirely an offer-for-sale of 5.96 crore shares, meaning the company will not receive fresh proceeds.
• Public bids can be placed between July 14 and July 16 at a price band of ₹540–570 per share.
• Anthem Biosciences posted FY25 revenue of ₹1,844.55 crore and a 22.86% rise in profit after tax to ₹451.26 crore.
• Shares are due to be allotted on July 17 and listed on the BSE and NSE on July 21 under the management of JM Financial, Citigroup, J.P. Morgan India and Nomura.